TrialNetworks

QuintilesIMS to buy DrugDev

Monday, June 26, 2017

QuintilesIMS has reportedly reached an agreement to buy DrugDev, a technology company that has built one of the industry’s largest global investigator networks and data sharing platforms, the latest in series of significant mergers among CROs during recent months.   

[Read More]

DrugDev hiring in Massachusetts

Monday, August 24, 2015

DrugDev, a health technology company, is putting out a call to SaaS developers in the Boston area to join the team behind a cloud-based software platform that enables clinical trial sponsors, CROs and sites to do more clinical trials together.

[Read More]

TrialNetworks wins Disruptive Technology and Innovator of the Year Award

Friday, April 11, 2014

TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014. The award honors an individual or a company with a new disruptive technology platform that has increased the efficiency and quality of clinical trials. TrialNetworks technology is used by companies including Merck, Biogen Idec, Ariad Pharmaceuticals and Infinity Pharmaceuticals to optimize clinical operations from startup through closeout.

[Read More]

TrialNetworks appoints Jorge G. Guerra advisory board chairman

Monday, January 20, 2014

Jorge G. Guerra, M.D., has joined TrialNetworks as chairman of the advisory board. The TrialNetworks platform, which began as an innovative site engagement and communication portal, has rapidly grown into a comprehensive cloud-based solution for key aspects of a clinical trial from startup through closeout, including feasibility surveys, training, trial conduct efficiency, patient recruitment and retention, site activation and document management.

[Read More]